Literature DB >> 20640405

Neuropsychological deficits in adolescent methamphetamine abusers.

George King1, Daniel Alicata, Christine Cloak, Linda Chang.   

Abstract

BACKGROUND: Methamphetamine (METH) is a widely abused psychostimulant that is associated with neurotoxicity and neurocognitive impairments in adults. However, the effects of METH use on neurocognitive performance of adolescents are unclear.
METHODS: Fifty-four adolescent METH users and 74 age-matched comparison subjects (ages 12 to 23 years) were evaluated with a battery of neuropsychological tests. The cognitive domains evaluated include psychomotor (Symbol Digit, Trail Making), executive function (Stroop Interference task, Wisconsin Card Sort task), fine-motor speed (Grooved Pegboard), memory (Digit span and Auditory Verbal Learning Task), as well as attention and working memory (California Computerized Assessment package).
RESULTS: METH users were slower on the Stroop Interference task than the comparison subjects (F(1,114) = 4.33, p = 0.03). METH subjects also performed worse than controls on the Wechsler Adult Intelligence Scale III/Wechsler Intelligence Scale for Children IV (WAIS/WISC) Matrices task (F(1,114) = 4.37, p = 0.04) and performed significantly worse on the Peg Board task than the comparison subjects for both the dominant (F(1,114) = 7.56, p = 0.01) and non-dominant (F(1,114) = 6.75, p = 0.01). Lastly, length of abstinence was associated with improved performance on the Peg Board test with the dominant had (r = -0.34), as well as the WAIS/WISC Forward Digit Span task (r = 0.38)
CONCLUSIONS: METH use is associated with impaired executive functions in adolescent users.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640405      PMCID: PMC2939179          DOI: 10.1007/s00213-010-1949-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

2.  Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study.

Authors:  T Ernst; L Chang; M Leonido-Yee; O Speck
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

3.  Psychiatric symptoms and HPA axis function in adolescent methamphetamine users.

Authors:  George King; Daniel Alicata; Christine Cloak; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-01       Impact factor: 4.147

4.  Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users.

Authors:  Linda Chang; Thomas Ernst; Oliver Speck; Hetal Patel; Menaka DeSilva; Maria Leonido-Yee; Eric N Miller
Journal:  Psychiatry Res       Date:  2002-06-15       Impact factor: 3.222

5.  Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; Y S Ding; M Sedler; J Logan; D Franceschi; J Gatley; R Hitzemann; A Gifford; C Wong; N Pappas
Journal:  Am J Psychiatry       Date:  2001-12       Impact factor: 18.112

6.  Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; M Leonido-Yee; D Franceschi; M J Sedler; S J Gatley; R Hitzemann; Y S Ding; J Logan; C Wong; E N Miller
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

7.  Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

Authors:  Y Sekine; M Iyo; Y Ouchi; T Matsunaga; H Tsukada; H Okada; E Yoshikawa; M Futatsubashi; N Takei; N Mori
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

Review 8.  Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment.

Authors:  C Davidson; A J Gow; T H Lee; E H Ellinwood
Journal:  Brain Res Brain Res Rev       Date:  2001-08

Review 9.  Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis.

Authors:  Jean Lud Cadet; Subramaniam Jayanthi; Xiaolin Deng
Journal:  FASEB J       Date:  2003-10       Impact factor: 5.191

Review 10.  Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review.

Authors:  Thomas E Nordahl; Ruth Salo; Martin Leamon
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

View more
  20 in total

1.  Long-term effects of early adolescent methamphetamine exposure on depression-like behavior and the hypothalamic vasopressin system in mice.

Authors:  Lauren Joca; Damian G Zuloaga; Jacob Raber; Jessica A Siegel
Journal:  Dev Neurosci       Date:  2014-03-27       Impact factor: 2.984

2.  Effects of adolescent methamphetamine and nicotine exposure on behavioral performance and MAP-2 immunoreactivity in the nucleus accumbens of adolescent mice.

Authors:  Jordan M Buck; Alysse S Morris; Sydney J Weber; Jacob Raber; Jessica A Siegel
Journal:  Behav Brain Res       Date:  2017-01-12       Impact factor: 3.332

Review 3.  AMPed-up adolescents: The role of age in the abuse of amphetamines and its consequences on cognition and prefrontal cortex development.

Authors:  Sara R Westbrook; Lauren K Carrica; Asia Banks; Joshua M Gulley
Journal:  Pharmacol Biochem Behav       Date:  2020-08-20       Impact factor: 3.533

4.  Long-term effects of neonatal methamphetamine exposure on cognitive function in adolescent mice.

Authors:  Jessica A Siegel; Byung S Park; Jacob Raber
Journal:  Behav Brain Res       Date:  2011-01-14       Impact factor: 3.332

5.  Metabolic alterations in the anterior cingulate cortex and related cognitive deficits in late adolescent methamphetamine users.

Authors:  Jieun E Kim; Geon Ha Kim; Jaeuk Hwang; Jung Yoon Kim; Perry F Renshaw; Deborah A Yurgelun-Todd; Binna Kim; Ilhyang Kang; Saerom Jeon; Jiyoung Ma; In Kyoon Lyoo; Sujung Yoon
Journal:  Addict Biol       Date:  2016-11-04       Impact factor: 4.280

6.  Age and sex effects levels of choline compounds in the anterior cingulate cortex of adolescent methamphetamine users.

Authors:  Christine C Cloak; Daniel Alicata; Linda Chang; Brian Andrews-Shigaki; Thomas Ernst
Journal:  Drug Alcohol Depend       Date:  2011-07-19       Impact factor: 4.492

7.  Striatum and insula dysfunction during reinforcement learning differentiates abstinent and relapsed methamphetamine-dependent individuals.

Authors:  Jennifer L Stewart; Colm G Connolly; April C May; Susan F Tapert; Marc Wittmann; Martin P Paulus
Journal:  Addiction       Date:  2013-12-15       Impact factor: 6.526

8.  Pilot randomized trial of bupropion for adolescent methamphetamine abuse/dependence.

Authors:  Keith G Heinzerling; Janette Gadzhyan; Henry van Oudheusden; Felipe Rodriguez; James McCracken; Steven Shoptaw
Journal:  J Adolesc Health       Date:  2013-01-17       Impact factor: 5.012

9.  Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana.

Authors:  Young-Hoon Sung; Paul D Carey; Dan J Stein; Helen L Ferrett; Bruce S Spottiswoode; Perry F Renshaw; Deborah A Yurgelun-Todd
Journal:  Behav Brain Res       Date:  2013-03-04       Impact factor: 3.332

Review 10.  An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans.

Authors:  Andy C Dean; Stephanie M Groman; Angelica M Morales; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2012-09-05       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.